ArticleTurkish journal of pharmaceutical sciences2022
Response Surface Methodology in Spectrophotometric Estimation of Saxagliptin, Derivatization with MBTH and Ninhydrin
Article in Turkish journal of pharmaceutical sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 5 citations in OpenAlex.
- Development and Characterization of a Plant-Based Chicken Nugget Analogue Based on Extruded Sacha Inchi Cake, Textured Soy Protein, and Wheat Gluten.Molecules (Basel, Switzerland) · 2026Article
- Analytical and Bioanalytical Methods for the Determination of Dipeptidyl Peptidase-4 Inhibitors in Various Matrices: A Comprehensive Review.Current diabetes reviews · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Design of experiments assisted spectrophotometric methods have been established for the quantification of saxagliptin in pharmaceutical formulation Materials and Methods: Box-Behnken design was exploited in method-1, involved the measurement of absorbance of green/blue-colored complex (at 600 nm), formed by the reaction of saxagliptin with 3-methyl-2-benzothiazolinone hydrazone in the presence of ferric chloride. The central composite design was employed in method-2, involved the determination of absorbance of Ruhemann's purple (at 585 nm), formed by the reaction of the primary amine group of saxagliptin with ninhydrin reagent in presence of sodium hydroxide. Optimization of reaction variables namely, reagent concentration (A), oxidizing agent/alkalinity (B) and reaction/heat time (C) was performed through response surface methodology for the response (Y) Results: Saxagliptin executed linearity in the concentration range of 0.01-0.25 μg/mL and 1-10 μg/mL by method-1 and 2. A high value of molar absorptivity, low values of Sandell's sensitivity and limit of detection/limit of quantification divulges the good sensitivity methods. The % assay of saxagliptin in the marketed formulation was found to be 100.27 and 99.86 by method-1 and method-2, respectively. Conclusion: The proposed eco-friendly and economical methods can be routinely employed in quality control for the analysis of saxagliptin in the pharmaceutical dosage forms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.